HICC® Berlin 2023 – Haemostasis in Critical Care

Dear Colleagues,

According to the increasing incidence of diseases caused by civilization (coronary heart disease, atrial fibrillation, stroke, peripheral arterial occlusive disease, venous thromboembolism, etc.), more and more patients are being treated with oral anticoagulants, platelet aggregation inhibitors or heparins - sometimes also in perioperative and intensive care treatment in combination – treated.

For anaesthesiologists, intensive care physicians, surgical colleagues and hemostasis specialists, this means that in the area of ​​conflict between thrombosis and bleeding, patients with anticoagulants and/or congenital or acquired coagulation disorders must be safely guided through perioperative and intensive care treatment.

In addition to the various hemostaseological clinical pictures (including hemophilia, von Willebrand syndrome, but also thrombophilic coagulation disorders) and the perioperatively acquired disorders of hemostasis (e.g. in mass transfusion, polytrauma, peripartum bleeding, etc.), the increasing number of highly effective anticoagulants, a profound knowledge of the possibilities of diagnostics (including point-of-care diagnostics) and haemostaseological therapy.

Therefore, the aim of this intensive workshop is to jointly work out the special features of patients with haemostaseological symptoms who need anticoagulant therapy, as well as hereditary and acquired coagulation disorders in perioperative and intensive care medicine, and thus to create the basis for effective and safe therapy.

In addition to "classic" lectures, we offer all these topics space and time for case discussions and small group work with subsequent discussion opportunities.

Together with the Society for Thrombosis and Haemostasis Research (GTH), we cordially invite you to this unique, interdisciplinary intensive workshop on all important aspects of perioperative and intensive care haemostasis.

We look forward to welcoming you in Berlin and St. Gallen!